| Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA P Bradley, F Frost, K Tharmaratnam, DG Wootton BMJ open respiratory research 7 (1), e000729, 2020 | 90 | 2020 |
| Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated … R Nightingale, N Nwosu, F Kutubudin, T Fletcher, J Lewis, F Frost, ... BMJ open respiratory research 7 (1), e000639, 2020 | 87 | 2020 |
| Ivacaftor is associated with reduced lung infection by key cystic fibrosis pathogens. A cohort study using national registry data FJ Frost, DS Nazareth, SC Charman, C Winstanley, MJ Walshaw Annals of the American Thoracic Society 16 (11), 1375-1382, 2019 | 80 | 2019 |
| Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes F Frost, P Dyce, D Nazareth, V Malone, MJ Walshaw Journal of Cystic Fibrosis 17 (6), 798-803, 2018 | 65 | 2018 |
| A direct comparison of decision rules for early discharge of suspected acute coronary syndromes in the era of high sensitivity troponin PG Chew, F Frost, L Mullen, M Fisher, H Zadeh, R Grainger, K Albouaini, ... European Heart Journal: Acute Cardiovascular Care 8 (5), 421-431, 2019 | 25 | 2019 |
| Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis F Frost, M Shaw, D Nazareth Cochrane Database of Systematic Reviews, 2019 | 25 | 2019 |
| Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis‐related diabetes F Frost, GH Jones, P Dyce, V Jackson, D Nazareth, MJ Walshaw Diabetic Medicine 36 (11), 1367-1374, 2019 | 19 | 2019 |
| Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach F Frost, P Dyce, A Ochota, S Pandya, T Clarke, MJ Walshaw, DS Nazareth Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 545-552, 2019 | 18 | 2019 |
| Case Report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis F Frost, D Nazareth F1000Research 7, 2018 | 11 | 2018 |
| Cystic fibrosis-related diabetes: an update F Frost, MJ Walshaw, D Nazareth QJM: An International Journal of Medicine 115 (9), 582-585, 2022 | 10 | 2022 |
| The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover … F Frost, GR Young, L Wright, N Miah, DL Smith, C Winstanley, ... Journal of Cystic Fibrosis 20 (6), 994-1002, 2021 | 10 | 2021 |
| The utility of established prognostic scores in COVID-19 hospital admissions: a multicentre prospective evaluation of CURB-65, NEWS2, and qSOFA F Frost, P Bradley, K Tharmaratnam, DG Wootton | 10 | 2020 |
| Research NWCOfR. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA P Bradley, F Frost, K Tharmaratnam, DG Wootton BMJ Open Respir Res 7 (1), e000729, 2020 | 10 | 2020 |
| Modified heart score improves early, safe discharge for suspected acute coronary syndromes: a prospective cohort study with recalibration of risk scores to undetectable high … A Khand, F Frost, P Chew, M Fisher, L Mullen, R Grainger, K Albouaini, ... Journal of the American College of Cardiology 69 (11S), 238-238, 2017 | 8 | 2017 |
| Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes A Toner, A McCloy, P Dyce, D Nazareth, F Frost Cochrane Database of Systematic Reviews, 2021 | 7 | 2021 |
| Case report: haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis J Yong, F Frost, D Nazareth, M Walshaw F1000Research 7, 2018 | 7 | 2018 |
| Identification of high-risk non-ST elevation myocardial infarction at presentation to emergency department. A prospective observational cohort study in North West England A Khand, F Frost, R Grainger, M Fisher, P Chew, L Mullen, B Patel, ... BMJ open 10 (6), e030128, 2020 | 6 | 2020 |
| Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study F Frost, D Nazareth, L Fauchier, D Wat, J Shelley, P Austin, MJ Walshaw, ... European Respiratory Journal 62 (4), 2023 | 5 | 2023 |
| Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry F Frost, D Nazareth, M Shaw, MJ Walshaw Journal of Cystic Fibrosis 18 (2), 294-298, 2019 | 5 | 2019 |
| S20 Inhaled aztreonam lysine recovers lung function and improves quality of life in acute pulmonary exacerbations of cystic fibrosis F Frost, J Fothergill, C Winstanley, D Nazareth, MJ Walshaw Thorax 74 (Suppl 2), A13-A14, 2019 | 4 | 2019 |
